Infection-based chemical screens uncover host-pathogen interactions

Area of Science:

• Microbiology
• Immunology
• Drug Discovery

Background:

• Bacterial pathogens require resistance to host innate immunity for disease establishment.
• Gram-negative bacteria possess an outer membrane, which, while protective, can be damaged by host factors, rendering them susceptible.
• Understanding bacterial vulnerability during host immune interactions is crucial for developing new anti-infective strategies.

Purpose of the Study:

• To develop and utilize a high-content screening platform for identifying compounds that enhance macrophage-mediated killing of bacterial pathogens.
• To discover novel compounds that specifically target bacterial pathogens within the host environment, particularly within macrophages.
• To explore new therapeutic avenues for combating bacterial infections by leveraging host immune mechanisms.

Main Methods:

• Development of a high-content screening platform for identifying compounds active against Salmonella enterica within macrophages.
• Assay development to measure bacterial survival and compound efficacy in a macrophage infection model.
• Characterization of hit compounds for their mechanism of action and activity in standard microbiological media.

Main Results:

• Successful implementation of a high-content screening platform for identifying anti-bacterial compounds.
• Discovery of multiple compounds that induce the killing of Salmonella enterica specifically within macrophages.
• Identification of compounds that are not active in standard media, suggesting a reliance on host-cell interactions or intracellular conditions.

Conclusions:

• The developed screening platform is effective for discovering host-dependent antibacterial compounds.
• Novel compounds have been identified that potentiate macrophage activity against Salmonella enterica.
• These findings open new avenues for developing therapeutics that work synergistically with the host immune system to fight bacterial infections.